Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 2 |
GO:0097014 | ciliary plasm | 5 | 2 |
GO:0099568 | cytoplasmic region | 3 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4Q4F1
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 130 | 134 | PF00656 | 0.601 |
CLV_NRD_NRD_1 | 86 | 88 | PF00675 | 0.413 |
CLV_NRD_NRD_1 | 93 | 95 | PF00675 | 0.463 |
CLV_PCSK_KEX2_1 | 93 | 95 | PF00082 | 0.429 |
CLV_PCSK_SKI1_1 | 87 | 91 | PF00082 | 0.497 |
DEG_SCF_FBW7_1 | 121 | 126 | PF00400 | 0.495 |
DOC_USP7_MATH_1 | 123 | 127 | PF00917 | 0.607 |
DOC_USP7_MATH_1 | 128 | 132 | PF00917 | 0.616 |
DOC_USP7_MATH_1 | 31 | 35 | PF00917 | 0.577 |
DOC_WW_Pin1_4 | 119 | 124 | PF00397 | 0.705 |
DOC_WW_Pin1_4 | 139 | 144 | PF00397 | 0.476 |
LIG_FHA_2 | 54 | 60 | PF00498 | 0.371 |
LIG_FHA_2 | 8 | 14 | PF00498 | 0.512 |
LIG_LIR_Gen_1 | 4 | 12 | PF02991 | 0.612 |
LIG_LIR_Nem_3 | 4 | 8 | PF02991 | 0.630 |
LIG_LIR_Nem_3 | 47 | 52 | PF02991 | 0.379 |
LIG_PCNA_PIPBox_1 | 95 | 104 | PF02747 | 0.425 |
LIG_PDZ_Class_1 | 139 | 144 | PF00595 | 0.487 |
LIG_SH2_NCK_1 | 27 | 31 | PF00017 | 0.434 |
LIG_SH2_STAT5 | 27 | 30 | PF00017 | 0.406 |
LIG_SH2_STAT5 | 48 | 51 | PF00017 | 0.491 |
LIG_TRAF2_1 | 30 | 33 | PF00917 | 0.544 |
MOD_CK2_1 | 124 | 130 | PF00069 | 0.486 |
MOD_CK2_1 | 7 | 13 | PF00069 | 0.528 |
MOD_CMANNOS | 51 | 54 | PF00535 | 0.421 |
MOD_GlcNHglycan | 126 | 129 | PF01048 | 0.690 |
MOD_GSK3_1 | 119 | 126 | PF00069 | 0.776 |
MOD_GSK3_1 | 135 | 142 | PF00069 | 0.533 |
MOD_NEK2_1 | 135 | 140 | PF00069 | 0.480 |
MOD_NEK2_1 | 52 | 57 | PF00069 | 0.442 |
MOD_ProDKin_1 | 119 | 125 | PF00069 | 0.705 |
MOD_SUMO_rev_2 | 12 | 21 | PF00179 | 0.566 |
TRG_ER_diArg_1 | 112 | 115 | PF00400 | 0.523 |
TRG_ER_diArg_1 | 92 | 94 | PF00400 | 0.530 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P6M0 | Leptomonas seymouri | 61% | 100% |
A0A1X0P0N5 | Trypanosomatidae | 60% | 100% |
A0A3Q8IJY7 | Leishmania donovani | 89% | 100% |
A0A422N525 | Trypanosoma rangeli | 58% | 100% |
A4HL94 | Leishmania braziliensis | 74% | 100% |
A4I8S0 | Leishmania infantum | 89% | 100% |
D0A4R2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 52% | 100% |
E9B3N6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
V5BBJ7 | Trypanosoma cruzi | 56% | 100% |